That was exactly the question asked by Sophion Bioscience A/S. So they developed together with thinXXS Microtechnology AG the QPlate - a completely new microfluidic lab on chip device, which considerably shortens the time for pharmaceutical companies to discover and develop new drugs for various disease areas.
The QPlate, manufactured by thinXXS, is the heart of Sophion’s QPatch HT and QPatch-16 systems. The systems allow for fully automated, parallel measurement of up to 48 ion channel currents in cell membranes (patch clamping). Ion channels are important targets in drug development since their controlled blocking or opening may have significant therapeutical effects.